Expert Outlook: Arcus Biosciences Through The Eyes Of 8 Analysts

專家展望：arcus biosciences在8位分析師眼中

Benzinga · 2024/11/06 20:00

During the last three months, 8 analysts shared their evaluations of Arcus Biosciences (NYSE:RCUS), revealing diverse outlooks from bullish to bearish.

在過去的三個月裏，8位分析師分享了對arcus biosciences（紐交所:RCUS）的評估，展示了從看好到看淡的多樣化展望。

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

下表提供了他們最近的評級概況，突出了過去30天內情緒的變化，並將其與之前的月份進行了比較。

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $25.12, with a high estimate of $30.00 and a low estimate of $20.00. Marking an increase of 1.17%, the current average surpasses the previous average price target of $24.83.

分析師對12個月價格目標的評估提供了額外的見解，展示了平均目標爲25.12美元，最高估值爲30.00美元，最低估值爲20.00美元。當前平均水平比之前的24.83美元的平均價格目標提高了1.17%。

Breaking Down Analyst Ratings: A Detailed Examination

分析師評級分析：詳細分析

The standing of Arcus Biosciences among financial experts...

通過對最近分析師...

登入免費觀看全文

登入/註冊

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。

Expert Outlook: Arcus Biosciences Through The Eyes Of 8 Analysts

Expert Outlook: Arcus Biosciences Through The Eyes Of 8 Analysts

風險及免責聲明

聲明